Beta-Amyloid (12-28) Peptide

Overview

The Beta-Amyloid (12-28) peptide is crucial for researchers studying Alzheimer’s disease, specifically its relationship with apolipoprotein E (apoE). This peptide represents a significant binding site that contributes to the aggregation of toxic amyloid beta (Aβ) peptides, a hallmark of Alzheimer’s pathology. Characterized by a hydrophobic domain and a distinctive secondary structure, Aβ (12-28) plays a pivotal role in the assembly of Aβ fibrils, making it an essential tool in neurobiological research. Our Beta-Amyloid (12-28) peptide enables precise studies into Alzheimer’s mechanisms, helping you stay at the forefront of Alzheimer’s research.

Key Features

• Represents a critical binding site for apolipoprotein E (apoE)
• Helps in understanding the aggregation process of toxic Aβ peptides
• Contains a hydrophobic domain for efficient fibril assembly
• Facilitates studies on Alzheimer’s disease mechanisms
• Available in high purity to support your research needs

Specifications

FAQ

What is the significance of the Beta-Amyloid (12-28) peptide?

This peptide serves as a binding site for apolipoprotein E (apoE), playing a central role in the aggregation process of amyloid beta, which is linked to Alzheimer’s disease.

How should I store the Beta-Amyloid (12-28) peptide?

It is recommended to store the peptide at -20°C to maintain its integrity and efficacy for your research applications.

Can Beta-Amyloid (12-28) be used in vivo?

This peptide is primarily intended for in vitro studies to explore Alzheimer’s disease mechanisms, rather than in vivo applications.

Order the Beta-Amyloid (12-28) peptide today for your research needs and enhance your understanding of Alzheimer’s disease. Explore our other peptides to find complementary products such as PKG Substrate and Autocamtide-2 for advanced experimental setups.

Related Products

• CREBtide [KRREILSRRPSYR], 5-FAM labeled